Targeted biocompatible nanoparticles for the delivery of (-)-epigallocatechin 3-gallate to prostate cancer cells.
about
Epigallocatechin Gallate Nanodelivery Systems for Cancer TherapyResveratrol and Omega-3 Fatty Acid: Its Implications in Cardiovascular DiseasesProstate cancer relevant antigens and enzymes for targeted drug deliveryTargeted therapy using nanotechnology: focus on cancerAn emerging interface between life science and nanotechnology: present status and prospects of reproductive healthcare aided by nano-biotechnologyGreen tea component epigallocatechin-3-gallate decreases expression of osteopontin via a decrease in mRNA half-life in cell lines of metastatic hepatocellular carcinomaAdvances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide familyGreen Tea Catechins for Prostate Cancer Prevention: Present Achievements and Future Challenges.Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model.Nanomedicine strategies for treatment of secondary spinal cord injury.How lipidomics provides new insight into drug discovery.Formulation of diblock polymeric nanoparticles through nanoprecipitation technique.Physical and chemical strategies for therapeutic delivery by using polymeric nanoparticles.Targeting prostate cancer cells with PSMA inhibitor-guided gold nanoparticles.Targeted polymeric therapeutic nanoparticles: design, development and clinical translationNanoparticle delivery of natural products in the prevention and treatment of cancers: current status and future prospects.Potential of magnetic nanoparticles for targeted drug deliveryNanoformulation of natural products for prevention and therapy of prostate cancer.Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals.NutriTRAILomics in prostate cancer: time to have two strings to one's bow.Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancerDesign, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery.Delivering flavonoids into solid tumors using nanotechnologies.Catechin prodrugs and analogs: a new array of chemical entities with improved pharmacological and pharmacokinetic properties.⁶⁴Cu-labeled inhibitors of prostate-specific membrane antigen for PET imaging of prostate cancer.Dose-Dependent Therapeutic Distinction between Active and Passive Targeting Revealed Using Transferrin-Coated PGMA Nanoparticles.Nanoencapsulation of natural triterpenoid celastrol for prostate cancer treatment.The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological diseaseSingle-step green synthesis and characterization of gold-conjugated polyphenol nanoparticles with antioxidant and biological activities.Augmented cellular uptake of nanoparticles using tea catechins: effect of surface modification on nanoparticle-cell interaction.Targeted nanoparticles encapsulating (-)-epigallocatechin-3-gallate for prostate cancer prevention and therapy.Recent Advances in Anticancer Activities and Drug Delivery Systems of Tannins.Resveratrol-loaded nanoparticles based on poly(epsilon-caprolactone) and poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) blend for prostate cancer treatment.Polyphenols delivery by polymeric materials: challenges in cancer treatment.Therapeutic Potential of Epigallocatechin Gallate Nanodelivery SystemsDevelopment of novel cationic chitosan-and anionic alginate-coated poly(D,L-lactide-co-glycolide) nanoparticles for controlled release and light protection of resveratrol.Anticancer activities of (-)-epigallocatechin-3-gallate encapsulated nanoliposomes in MCF7 breast cancer cells.Folic acid on iron oxide nanoparticles: platform with high potential for simultaneous targeting, MRI detection and hyperthermia treatment of lymph node metastases of prostate cancer.
P2860
Q26746909-A22725A3-23FE-4DF0-BB08-8221ABFDB2F7Q26772210-59526BF1-26FC-44B9-B6D1-A066F08CCC77Q27013843-B484E8FE-3F74-4BCD-BF2F-2F7EE56BB6E3Q27023361-93B1F015-CE3F-49C3-9B68-005B72F4E94AQ28658189-4D8D12C8-7959-4201-A3DF-3FFCA94218B6Q28821563-F6F35289-8395-4232-9D79-2F7BB6B5E55BQ30465259-C6A0EA29-E949-44E5-A9DB-680232B143ACQ33845027-9F7AC585-E3F7-42A5-86C0-61F51CB7F66FQ35000546-75FF27DB-47C8-4AE8-BD44-6BC0C8966841Q35063603-6ECCE40B-741A-4BDE-9E28-37EE1CA5858EQ35167171-DC882FF5-F229-4457-A4B2-7347ECF32864Q35591231-E810F939-72F9-4606-A448-3B8635B1E358Q36105465-DD764C4B-178D-463C-885A-56F97765ED77Q36501550-A2E11BD1-0DA5-4ED0-91E5-6A534EFB58BAQ36934007-A55B926F-7E77-4716-8F05-684A17906911Q37148172-67F18805-A01A-4A8F-8DDD-C09BE92CDD36Q37194054-5B7E133F-D8AC-4FA2-A663-C9F533D6C2DAQ37473193-D8F1F532-1EC3-452F-AF2D-1DB8A0CE3449Q37646827-86125C83-4766-4519-B752-9F0869DB279FQ37965036-B269E39F-4A3C-49DB-A371-3D6628D7867CQ37972920-A7154286-07D4-4C12-8221-DA0BCD69477EQ38067265-6B702FA9-9385-4E6E-9AE3-546A415C6513Q38122177-571B17CA-993C-409B-A338-63492F58ED56Q38140631-02ABF9BE-534C-4077-916F-9BF131243002Q38705627-0A623E53-1A8B-49A6-A076-09F2BD3F15FBQ38815759-7548FBCC-2264-425B-989C-ABA7E7FB023BQ38818143-AF6CE114-E5A5-45FD-A22C-0DC61B159C41Q38831232-C8544148-6CCF-4474-9B34-648FBB660CF7Q38943270-0AB3638E-516D-4F15-8B96-348D3FD4D953Q38971012-8B4535A7-EA82-451E-8625-90410FD1844FQ38987405-9C1EF3D2-3533-4751-B47D-996AA9F64769Q39048429-9E197489-480B-4932-860E-495B6244BB0CQ39106653-977B2037-6FCD-40EF-BAEF-28256A2A0C91Q39117499-26ECBE30-A0F3-44CF-B72D-32675DA040DBQ41169121-4A010E4D-A573-46B0-AFDA-06300FCCCB83Q41973058-A53EF1A1-6D53-463F-9127-7CFB4AB7C545Q45833032-E35A5F6D-7F93-46FF-8A0C-C09F0BD3FC6BQ50073061-43AD70A5-D11F-4227-8DD3-441232BCAC1E
P2860
Targeted biocompatible nanoparticles for the delivery of (-)-epigallocatechin 3-gallate to prostate cancer cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Targeted biocompatible nanopar ...... late to prostate cancer cells.
@en
Targeted biocompatible nanoparticles for the delivery of
@nl
type
label
Targeted biocompatible nanopar ...... late to prostate cancer cells.
@en
Targeted biocompatible nanoparticles for the delivery of
@nl
prefLabel
Targeted biocompatible nanopar ...... late to prostate cancer cells.
@en
Targeted biocompatible nanoparticles for the delivery of
@nl
P2093
P50
P356
P1476
Targeted biocompatible nanopar ...... late to prostate cancer cells.
@en
P2093
Alessandro Arca
Anna Maria Posadino
Anna Maria Roggio
Gianfranco Pintus
Pasquale Bandiera
Sergio Uzzau
Stefania Punzoni
P304
P356
10.1021/JM1013715
P407
P577
2011-02-09T00:00:00Z